FDA Inspection 1229751 — Rhode Island Blood Center, a Division of New York Blood Center, Inc. Warwick Donor Center

Rhode Island Blood Center, a Division of New York Blood Center, Inc. Warwick Donor Center — FEI 3003126048

The FDA completed an inspection of Rhode Island Blood Center, a Division of New York Blood Center, Inc. Warwick Donor Center on January 5, 2024 in Warwick, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 5, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Warwick, RI (United States)